Eleventh Circuit Upholds Whistleblower Fraud Suits, Reviving a Florida Medicare Case

The United States Court of Appeals for the Eleventh Circuit has ruled that the whistleblower provisions of the False Claims Act do not violate Article II of the Constitution, reversing a Florida district judge whose decision had threatened one of the federal government's most effective fraud enforcement tools. The unanimous three-judge panel held in Zafirov v. Florida Medical Associates LLC that private citizens who sue on behalf of the United States are not unconstitutionally appointed federal officers, reviving a Medicare Advantage fraud lawsuit against a Florida health care network.

What the court decided

The question before the panel was whether the False Claims Act's qui tam provisions, which allow a private party known as a relator to file suit on behalf of the United States and share in any recovery, unconstitutionally vest executive power in someone who was never appointed under the Appointments Clause.

The court applied the two-part test used to determine whether someone qualifies as an officer of the United States. It concluded that relators fail the first prong because they do not occupy a continuing position. A relator files a particular case, litigates it and receives a share of any recovery, then has no ongoing role or authority.

Because relators are not officers, the court held, the Appointments Clause does not apply to them, and the qui tam structure does not offend Article II's vesting of executive power in the President. The ruling was unanimous across the three-judge panel.

The decision reverses a district court ruling from Florida that had reached the opposite conclusion. That earlier ruling drew national attention precisely because it threatened a statutory mechanism that produces a substantial share of federal fraud recoveries every year.

The underlying Florida case

The suit was brought by Dr. Clarissa Zafirov, a board-certified family care physician, against her former employer, which does business as VIPcare. Zafirov alleged that the organization systematically submitted false Medicare Advantage diagnosis codes in order to inflate the monthly risk-adjustment payments it received.

Medicare Advantage pays participating plans a fixed monthly amount per enrollee, adjusted upward for patients with more serious conditions. That risk-adjustment mechanism is intended to ensure plans are not penalized for enrolling sicker patients, but it creates a financial incentive to record diagnoses that make patients appear sicker than they are.

Allegations of diagnosis code inflation have become among the most common categories of Medicare Advantage fraud claims nationally, and the Department of Justice has pursued a number of such cases. The mechanics are difficult to detect from outside an organization, which is precisely why whistleblower suits matter in this area.

The Eleventh Circuit's ruling reinstates Zafirov's case, returning it to the district court for further proceedings. The ruling resolves the constitutional question rather than the merits, and nothing in the decision determines whether the underlying allegations are true.

Why the False Claims Act matters

The False Claims Act dates to the Civil War, when it was enacted to address fraud by contractors supplying the Union Army. Its qui tam provision, allowing private parties to sue on the government's behalf, has been part of the statute since its origin and was strengthened by Congress in 1986.

The mechanism works by aligning private incentives with public enforcement. A relator who has inside knowledge of fraud files a sealed complaint, the government investigates and may intervene, and the relator receives a percentage of any recovery. Treble damages and per-claim penalties make the statute financially significant for defendants.

Qui tam cases account for a large share of federal fraud recoveries in a typical year, with health care fraud the dominant category. Removing the mechanism would have shifted the entire burden of detection onto federal agencies, which lack the inside visibility that employees possess.

The constitutional challenge to that structure had been developing for several years, supported by arguments that a private party wielding the government's litigation authority exercises executive power without accountability to the executive branch.

The Florida angle

Florida is central to this area of law for reasons of demography and market structure. The state has one of the largest Medicare populations in the country and among the highest Medicare Advantage penetration rates, which makes it a focal point for both the payment model and the fraud enforcement built around it.

Federal prosecutors in Florida's Middle and Southern Districts handle a substantial volume of health care fraud matters, and the state has been the source of many of the most significant Medicare fraud prosecutions of the past two decades. A ruling eliminating qui tam suits would have removed a primary detection channel in the state where it matters most.

Florida's health care sector is also among its largest employers, with education and health services adding 39,600 positions over the year according to state labor data. The regulatory and enforcement environment around that sector has direct economic consequences in the state.

The case arose in Florida, was decided against the government by a Florida district judge, and has now been reversed by the appellate court with jurisdiction over Florida, Georgia and Alabama.

What it means for Florida patients

For Medicare beneficiaries in Florida, the practical stake is the integrity of a program that covers a substantial share of the state's older residents. Risk-adjustment fraud inflates program costs without improving care, and those costs ultimately flow through to premiums and to the federal budget.

Inaccurate diagnosis coding can also affect individual patients directly. A diagnosis recorded in a patient's record that does not reflect their actual condition can influence future treatment decisions, insurance underwriting in other contexts and the patient's own understanding of their health.

Patients who suspect their records contain diagnoses they do not have can request their medical records and their Medicare summary notices, which list services billed on their behalf. Discrepancies can be reported to Medicare, and Florida operates a Senior Medicare Patrol program that assists beneficiaries with exactly this kind of review.

None of that is altered by the ruling itself, but the decision preserves the enforcement mechanism through which systematic problems are most often surfaced.

What it means for Florida employers

For health care organizations operating in Florida, the ruling restores the compliance environment that existed before the district court decision. Organizations that bill federal health care programs face qui tam exposure from their own employees, and that exposure shapes compliance investment.

Compliance programs in the health care sector are built substantially around the False Claims Act. Internal reporting channels, coding audits and documentation standards exist in large part because the statute makes systematic billing errors financially dangerous.

The ruling also reinforces the legal protection available to employees who report suspected fraud. The False Claims Act includes anti-retaliation provisions, and physicians and coders who raise concerns internally operate against that statutory backdrop.

For defense counsel, the decision closes off a constitutional argument that had briefly appeared viable within the Eleventh Circuit and returns the focus to the merits of individual cases.

The broader legal picture

The constitutional challenge to qui tam has been litigated in multiple circuits, and the Eleventh Circuit's decision aligns with the general weight of appellate authority upholding the mechanism. A circuit split on a question of this significance would be a strong candidate for Supreme Court review.

The panel's reasoning, resting on the conclusion that relators do not occupy a continuing position and therefore are not officers, is narrow in the sense that it resolves the case on the first prong of the officer test without reaching broader questions about executive power.

Defendants retain the option of seeking rehearing before the full Eleventh Circuit or petitioning the Supreme Court. Neither step is automatic, and the unanimity of the panel decision makes en banc review less likely than a divided ruling would.

Until any further review, the decision is binding law in Florida, Georgia and Alabama, and qui tam cases in those states proceed under the framework the panel confirmed.

How a qui tam case actually proceeds

The procedure is unusual and worth understanding. A relator files the complaint under seal, meaning it is not public and the defendant is not notified. The government then investigates, typically for months and sometimes for years, while the case remains sealed.

At the end of that period the government decides whether to intervene and take over the litigation. Intervention substantially increases the likelihood of recovery, because the resources of the Department of Justice come to bear and defendants assess settlement prospects accordingly.

If the government declines, the relator may proceed alone. Those cases are harder to win and are pursued by specialized plaintiffs firms that take them on contingency, with the relator's share of any recovery larger when the government has not intervened.

The seal period is what makes the mechanism effective. A defendant unaware that a complaint has been filed continues operating normally while the government gathers evidence, which is why the structure has survived repeated attempts to dismantle it.

What's next

Zafirov's case returns to the district court for proceedings on the merits, where the allegations about diagnosis coding will be tested through discovery and, if the case does not resolve, at trial. The constitutional ruling does not address whether the conduct alleged occurred.

Other qui tam cases in the Eleventh Circuit that had been affected by the district court ruling will now proceed under the restored framework, and cases that had been paused pending the appeal can resume.

Whether the Supreme Court takes up the qui tam question in a future term depends on whether a circuit split develops. For now, the appellate courts that have addressed it have largely converged.

For Florida's health care sector and the federal programs that fund a large part of it, the immediate consequence is continuity: the principal mechanism through which billing fraud is detected and prosecuted remains in place.